ITMCTR2200006777
Recruiting
未知
Clinical observation on the treatment of Parkinson's disease with fatigue by three injections
The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD
ConditionsParkinson's disease fatigue
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Parkinson's disease fatigue
- Sponsor
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Meet the diagnostic criteria of PD (refer to the MDS: Clinical diagnostic criteria for Parkinson's Disease revised by the International Movement Disorders Association in 2015\);
- •? Male or female, aged 35\-75 years;
- •? Total score of Fatigue Severity Rating Scale (FSS) /9 \>4
- •? Subjects should know the protocol and sign the informed consent.
Exclusion Criteria
- •?Patients with serious other systemic diseases, such as immune system diseases, endocrine system diseases (such as pheochromocytoma, hyperthyroidism, etc.), respiratory system diseases, cardiovascular and cerebrovascular diseases, or liver and kidney insufficiency.
- •(2\) Clear can lead to Parkinson's syndrome or suspected symptoms related to other diseases, such as Parkinson's syndrome, senile tremor, etc.
- •?There was definite cerebellar ataxia or cerebellar eye movement abnormalities.
- •?There was definite loss of compound sensory cortex and motor apraxia or progressive aphasia.
- •?Downward vertical supranuclear gaze palsy or downward vertical saccade selective slowing.
- •?Parkinson\-like symptoms that remain confined to the lower extremities three years after onset.
- •?Highly suspected behavioral variant frontotemporal dementia or primary progressive aphasia was diagnosed within 5 years of onset
- •?There was no significant therapeutic response to high\-dose levodopa treatment.
- •?Patients with a clear history of mental illness or psychotic symptoms, such as depression, schizophrenia, etc.
- •?Have a history of substance abuse (such as alcohol, drugs, caffeine), sleeping pills or psychoactive drugs in the past six months.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A Clinical Study for the Treatment of Parkinson's Disease with Integrated Shi Shi Tonifying Kidney Pill and Xingnao Kaiqiao AcupunctureParkinson's diseaseITMCTR1900002280ShenZhen JinFangZhenLue Technology Ltd. Co.
Not yet recruiting
Not Applicable
A Clinical study of Parkinsonâ??s disease and comparativr evaluation of two unani formulations (Combination of jadwar and ood e saleeb with majoon e jograj gogul) in its management.Health Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereHealth Condition 2: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereCTRI/2021/09/036722Department of Moalejat
Not yet recruiting
Not Applicable
Prospective Observation Study on Parkinson’s Disease PatientsDiseases of the nervous systemKCT0007238Daejeon Korean Medicine Hospital of Daejeon University40
Recruiting
Not Applicable
Outcome of Parkinson's disease patients after orthopedic surgeryG20.9DRKS00014309Medizinische Hochschule Hannover70
Recruiting
Phase 2
Treatment of non-motor symptoms of Parkinson's disease with CannabidiolParkinson's DiseaseChronic PainRBR-3tvjjkxHospital da Clínicas da Faculdade de Medicina da Universidade de São Paulo